78,25 €
0,79 % gestern
L&S, 25. November, 22:54 Uhr
ISIN
US2942681071
Symbol
PLUS
Berichte

ePlus inc. Aktie News

Positiv
The Motley Fool
18 Tage alt
It notched a beat-and-raise fiscal second quarter. It's also modeling double-digit increases in key fundamentals for the full fiscal year.
Neutral
Seeking Alpha
19 Tage alt
ePlus inc. ( PLUS ) Q2 2026 Earnings Call November 6, 2025 4:30 PM EST Company Participants Amanda Dupree Mark Marron - CEO, President & Director Elaine Marion - Chief Financial Officer Conference Call Participants Margaret Nolan - William Blair & Company L.L.C., Research Division Gregory Burns - Sidoti & Company, LLC Presentation Operator Good day, ladies and gentlemen.
Neutral
PRNewsWire
19 Tage alt
Raises Fiscal 2026 Guidance Amid Double Digit Growth Year Over Year in Second Quarter Revenue, Gross Profit, Net Earnings and Earnings Per Share ~Announces Common Stock Quarterly Dividend of $0.25 Per Share ~ Second Quarter Fiscal Year 2026 Consolidated net sales increased 23.4% to $608.8 million; services revenues increased 19.4% to $123.8 million. Gross billings increased 26.5% to $1,022.7 mi...
Neutral
PRNewsWire
26 Tage alt
HERNDON, Va., Oct. 30, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS – news) today announced that on November 6, 2025, it will release earnings and host a conference call regarding its financial results for the three and six months ended September 30, 2025. Earnings will be released after the market closes, and management will hold a conference call and audio webcast at 4:30 p.m. ET.
Neutral
PRNewsWire
etwa ein Monat alt
Nearly Three Out of Four IT and Industry Leaders Now Prioritize Revenue Growth as Main Driver of AI Initiatives, Over Cost Savings and Increased Customer Satisfaction HERNDON, Va. , Oct. 21, 2025 /PRNewswire/ -- ePlus inc.
Neutral
PRNewsWire
etwa 2 Monate alt
Provides Simplified Operational Support and Increased Visibility Across the Network HERNDON, Va. , Sept. 30, 2025 /PRNewswire/ -- ePlus inc.
Positiv
24/7 Wall Street
2 Monate alt
Shares of clinical-stage pharmaceutical company, Plus Therapeutics, are up about 31% on a volume spike of 216.4 million
Neutral
Seeking Alpha
2 Monate alt
ePlus inc. (NASDAQ:PLUS ) Q1 2026 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Elaine D. Marion - Chief Financial Officer Kleyton L.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen